Sector ratings United Therapeutics Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 14:52:40 09/12/2025 GMT			5-day change	1st Jan Change
480.52 ^USD	+0.21%		+1.17%	+35.96%

12-08	United Therapeutics Insider Sold Shares Worth $3,870,056, According to a Recent SEC Filing	MT
12-05	United Therapeutics Insider Sold Shares Worth $3,821,130, According to a Recent SEC Filing	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
UNITED THERAPEUTICS CORPORATION	20.65B		A
ELI LILLY AND COMPANY	893B		A
JOHNSON & JOHNSON	486B		BBB
ABBVIE INC.	394B		AA
ROCHE HOLDING AG	336B		AA
ASTRAZENECA PLC	280B		A
NOVARTIS AG	253B		AAA
MERCK & CO., INC.	246B		A
NOVO NORDISK A/S	207B		A
AMGEN INC.	173B		A
GILEAD SCIENCES, INC.	150B		AAA
PFIZER INC.	147B		BBB
SANOFI	118B		A
VERTEX PHARMACEUTICALS INCORPORATED	112B		AA
BRISTOL-MYERS SQUIBB COMPANY	105B		A
GSK PLC	97.31B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	86.79B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
ALNYLAM PHARMACEUTICALS, INC.	56.81B		AA	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	58.65B		AA
Average	214.23B		AA
Weighted average by Cap.			AA